Suppression of E-cadherin mediates gallotannin induced apoptosis in Hep G2 hepatocelluar carcinoma cells

International Journal of Biological Sciences

Volumn 10, Issue 5, 2014, Pages 490-499

  Han, Hee Jeong ^a   Kwon, Hee Young ^a   Sohn, Eun Jung ^a   Ko, Hyusuk ^a   Kim, Bogeun ^a   Jung, Kwon ^a   Lew, Jae Hwan ^a   Kim, Sung Hoon ^a  

^a Kyung Hee University   (South Korea)

Author keywords

Apoptosis; Caspase; E cadherin; Gallotannin; Hep G2 cells; PARP

Indexed keywords

ANTINEOPLASTIC AGENT; CADHERIN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; SMALL INTERFERING RNA; TANNIN;

APOPTOSIS; DRUG EFFECTS; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION; GENETICS; HEPG2 CELL LINE; HUMAN; LIVER CELL CARCINOMA; LIVER TUMOR; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; RNA INTERFERENCE; TUNEL ASSAY;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CADHERINS; CARCINOMA, HEPATOCELLULAR; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION, NEOPLASTIC; HEP G2 CELLS; HUMANS; HYDROLYZABLE TANNINS; IN SITU NICK-END LABELING; LIVER NEOPLASMS; POLY(ADP-RIBOSE) POLYMERASES; RNA INTERFERENCE; RNA, SMALL INTERFERING;

EID: 84899755631     PISSN: 14492288     EISSN: None     Source Type: Journal    
DOI: 10.7150/ijbs.7495     Document Type: Article

References (41)

1. Baffy G, Brunt EM, Caldwell SH. Hepatocellular carcinoma in non-alcoholic fatty liver disease: an emerging menace. J Hepatol 2012; 56(6): 1384-91.
2. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, et al. Cancer statistics, 2008. CA Cancer J Clin 2008; 58(2): 71-96.
3. Villanueva A, Llovet JM. Second-line therapies in hepatocellular carcinoma: emergence of resistance to sorafenib. Clin Cancer Res 2012; 18(7): 1824-6.
4. Sun Z, Liang ST, Zhai XF, Lang QB, Zhou QH, Yue XQ, et al. A traditional Chinese herbal medicine compound preparation versus interventional therapy after resection of small hepatocellular carcinoma: 22-year follow-up. J Tradit Chin Med 2012; 32(2): 156-63.
5. Li Y, Martin RCG. Herbal medicine and hepatocellular carcinoma: applications and challenges. Evid Based Complement Alternat Med; 2011;: 541209.
6. Yu Y, Lang Q, Chen Z, Li B, Yu C, Zhu D, et al. The efficacy for unresectable hepatocellular carcinoma may be improved by transcatheter arterial chemoembolization in combination with a traditional Chinese herbal medicine formula: a retrospective study. Cancer 2009; 115(22): 5132-8.
7. Huang XY, Wang L, Huang ZL, Zheng Q, Li QS, Tang ZY. Herbal extract "Songyou Yin" inhibits tumor growth and prolongs survival in nude mice bearing human hepatocellular carcinoma xenograft with high metastatic potential. J Cancer Res Clin Oncol 2009; 135(9): 1245-55.
8. Li Y, Martin RC, 2nd. Herbal medicine and hepatocellular carcinoma: applications and challenges. Evid Based Complement Alternat Med 2011; 2011: 541209.
9. Tsuchiya M, Kono H, Matsuda M, Fujii H, Rusyn I. Protective effect of Juzen-taiho-to on hepatocarcinogenesis is mediated through the inhibition of Kupffer cell-induced oxidative stress. Int J Cancer 2008; 123(11): 2503-11.
10. Oka H, Yamamoto S, Kuroki T, Harihara S, Marumo T, Kim SR, et al. Prospective study of chemoprevention of hepatocellular carcinoma with Sho-saiko-to (TJ-9). Cancer 1995; 76(5): 743-9.
11. Erdelyi K, Kiss A, Bakondi E, Bai P, Szabo C, Gergely P, et al. Gallotannin inhibits the expression of chemokines and inflammatory cytokines in A549 cells. Mol Pharmacol 2005; 68(3): 895-904.
12. Zhao X, Sun H, Hou A, Zhao Q, Wei T, Xin W. Antioxidant properties of two gallotannins isolated from the leaves of Pistacia weinmannifolia. Biochim Biophys Acta 2005; 1725(1): 103-10.
13. Engels C, Knodler M, Zhao YY, Carle R, Ganzle MG, Schieber A. Antimicrobial activity of gallotannins isolated from mango (Mangifera indica L.) kernels. J Agric Food Chem 2009; 57(17): 7712-8.
14. Lee HJ, Jeong SJ, Park MN, Linnes M, Han HJ, Kim JH, et al. Gallotannin suppresses calcium oxalate crystal binding and oxalate-induced oxidative stress in renal epithelial cells. Biol Pharm Bull 2012; 35(4): 539-44.
15. Al-Ayyoubi S, Gali-Muhtasib H. Differential apoptosis by gallotannin in human colon cancer cells with distinct p53 status. Mol Carcinog 2007; 46(3): 176-86.
16. Yu S-M, Gweon E-J, Chung K-W, Kim K-H, Cho H-S, Kim S-J. Gallotannin regulates apoptosis and COX-2 expression via Akt and p38kinase pathway in human lung cancer cell line, A549. Animal Cells and Systems 2012; 16(5): 366-375.
17. Schmalhofer O, Brabletz S, Brabletz T. E-cadherin, beta-catenin, and ZEB1 in malignant progression of cancer. Cancer Metastasis Rev 2009; 28(1-2): 151-66.
18. Brabletz T, Hlubek F, Spaderna S, Schmalhofer O, Hiendlmeyer E, Jung A, et al. Invasion and metastasis in colorectal cancer: epithelial-mesenchymal transition, mesenchymal-epithelial transition, stem cells and beta-catenin. Cells Tissues Organs 2005; 179(1-2): 56-65.
19. Nollet F, Berx G, van Roy F. The role of the E-cadherin/catenin adhesion complex in the development and progression of cancer. Mol Cell Biol Res Commun 1999; 2(2): 77-85.
20. Schmeiser K, Grand RJ. The fate of E-and P-cadherin during the early stages of apoptosis. Cell Death Differ 1999; 6(4): 377-86.
21. Kang HG, Jenabi JM, Zhang J, Keshelava N, Shimada H, May WA, et al. E-cadherin cell-cell adhesion in ewing tumor cells mediates suppression of anoikis through activation of the ErbB4 tyrosine kinase. Cancer Res 2007; 67(7): 3094-105.
22. Galaz S, Espada J, Stockert JC, Pacheco M, Sanz-Rodriguez F, Arranz R, et al. Loss of E-cadherin mediated cell-cell adhesion as an early trigger of apoptosis induced by photodynamic treatment. J Cell Physiol 2005; 205(1): 86-96.
23. Fouquet S, Lugo-Martinez VH, Faussat AM, Renaud F, Cardot P, Chambaz J, et al. Early loss of E-cadherin from cell-cell contacts is involved in the onset of Anoikis in enterocytes. J Biol Chem 2004; 279(41): 43061-9.
24. Chen LG, Huang WT, Lee LT, Wang CC. Ellagitannins from Terminalia calamansanai induced apoptosis in HL-60 cells. Toxicol In Vitro 2009; 23(4): 603-9.
25. Chung WG, Miranda CL, Stevens JF, Maier CS. Hop proanthocyanidins induce apoptosis, protein carbonylation, and cytoskeleton disorganization in human colorectal adenocarcinoma cells via reactive oxygen species. Food Chem Toxicol 2009; 47(4): 827-36.
26. Kwon TR, Jeong SJ, Lee HJ, Sohn EJ, Jung JH, Kim JH, et al. Reactive oxygen species-mediated activation of JNK and down-regulation of DAXX are critically involved in penta-O-galloyl-beta-d-glucose-induced apoptosis in chronic myeloid leukemia K562 cells. Biochem Biophys Res Commun 2012; 424(3): 530-7.
27. Hu H, Zhang J, Lee HJ, Kim SH, Lu J. Penta-O-galloyl-beta-D-glucose induces S-and G(1)-cell cycle arrests in prostate cancer cells targeting DNA replication and cyclin D1. Carcinogenesis 2009; 30(5): 818-23.
28. Huh JE, Lee EO, Kim MS, Kang KS, Kim CH, Cha BC, et al. Penta-O-galloyl-beta-D-glucose suppresses tumor growth via inhibition of angiogenesis and stimulation of apoptosis: roles of cyclooxygenase-2 and mitogen-activated protein kinase pathways. Carcinogenesis 2005; 26(8): 1436-45.
29. Al-Halabi R, Bou Chedid M, Abou Merhi R, El-Hajj H, Zahr H, Schneider-Stock R, et al. Gallotannin inhibits NFkB signaling and growth of human colon cancer xenografts. Cancer Biol Ther 2011; 12(1): 59-68.
30. Uruena C, Mancipe J, Hernandez J, Castaneda D, Pombo L, Gomez A, et al. Gallotannin-rich Caesalpinia spinosa fraction decreases the primary tumor and factors associated with poor prognosis in a murine breast cancer model. BMC Complement Altern Med 2013; 13: 74.
31. Ouyang L, Shi Z, Zhao S, Wang FT, Zhou TT, Liu B, et al. Programmed cell death pathways in cancer: a review of apoptosis, autophagy and programmed necrosis. Cell Prolif 2012; 45(6): 487-98.
32. Elmore S. Apoptosis: a review of programmed cell death. Toxicol Pathol 2007; 35(4): 495-516.
33. Gama A, Schmitt F. Cadherin cell adhesion system in canine mammary cancer: a review. Vet Med Int; 2012; 2012: 357187-95.
34. Yap AS. The morphogenetic role of cadherin cell adhesion molecules in human cancer: a thematic review. Cancer Invest 1998; 16(4): 252-61.
35. Raftopoulos I, Kouraklis G. Dysfunction of the E-cadherin/catenin cell adhesion cascade in epithelial cancers (Review). Oncol Rep 1996; 3(4): 793-803.
36. Wheelock MJ, Soler AP, Knudsen KA. Cadherin junctions in mammary tumors. J Mammary Gland Biol Neoplasia 2001; 6(3): 275-85.
37. Frisch SM, Ruoslahti E. Integrins and anoikis. Curr Opin Cell Biol 1997; 9(5): 701-6.
38. Peluso JJ, Pappalardo A, Fernandez G. E-cadherin-mediated cell contact prevents apoptosis of spontaneously immortalized granulosa cells by regulating Akt kinase activity. Biol Reprod 2001; 64(4): 1183-90.
39. Pece S, Gutkind JS. E-cadherin and Hakai: signalling, remodeling or destruction? Nat Cell Biol 2002; 4(4): E72-4.
40. Steinhusen U, Weiske J, Badock V, Tauber R, Bommert K, Huber O. Cleavage and shedding of E-cadherin after induction of apoptosis. J Biol Chem 2001; 276(7): 4972-80.
41. Steinhusen U, Badock V, Bauer A, Behrens J, Wittman-Liebold B, Dorken B, et al. Apoptosis-induced cleavage of beta-catenin by caspase-3 results in proteolytic fragments with reduced transactivation potential. J Biol Chem 2000; 275(21): 16345-53.